Pain Exposure Hinders Brain Development in Preterm Infants Pain Exposure Hinders Brain Development in Preterm Infants
An observational study of preterm infants exposed to pain early in life found sex-specific differences in the development of brain connectivity.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 25, 2024 Category: Neurology Tags: Pediatrics Source Type: news

FDA OKs Givinostat for Duchenne Muscular Dystrophy FDA OKs Givinostat for Duchenne Muscular Dystrophy
Givinostat (Duvyzat), a histone deacetylase inhibitor, is the first nonsteroidal drug approved to treat patients aged 6 years or older with all genetic variants of DMD.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 22, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Glucose Level Fluctuations Affect Cognition in T1D Glucose Level Fluctuations Affect Cognition in T1D
Glucose levels can affect processing speed and other cognitive functions, suggesting that minimizing glucose fluctuations is important for optimizing cognitive performance.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 21, 2024 Category: Neurology Tags: Diabetes & Endocrinology Source Type: news

Promising Phase 3 Data on DMD Hopeful Givinostat Promising Phase 3 Data on DMD Hopeful Givinostat
Treatment with the investigational agent givinostat has the potential to delay disease progression when added to corticosteroid treatment in ambulatory boys with Duchenne muscular dystrophy.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 21, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

FDA OKs Gene Therapy for Metachromatic Leukodystrophy FDA OKs Gene Therapy for Metachromatic Leukodystrophy
Atidarsagene autotemcel (Lenmeldy) is approved for presymptomatic late infantile, presymptomatic early juvenile, or early symptomatic early juvenile MLD.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 19, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Neurologic Genetic Testing Is Less Likely in Black Patients Neurologic Genetic Testing Is Less Likely in Black Patients
Investigators found significant Black patients are significantly less likely than their White counterparts to receive genetic testing for neurologic disorders, new research shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 19, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

FDA's New Guidance for Early Alzheimer's Drug Development FDA's New Guidance for Early Alzheimer's Drug Development
The FDA embraces the use of biomarkers and surrogate endpoints in its most recent guidance on developing therapeutics for early Alzheimer ’s disease.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 19, 2024 Category: Neurology Tags: Psychiatry Source Type: news

Adults With Late-Onset MS at High Risk for Rapid Progression Adults With Late-Onset MS at High Risk for Rapid Progression
MS that develops after age 50 tends to progress more rapidly than younger-onset MS and is less apt to respond to disease-modifying therapy, Swedish registry data show.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 15, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Neurologic Disorders Now Top Cause of Illness, Disability Neurologic Disorders Now Top Cause of Illness, Disability
Neurologic conditions are now the leading cause of illness and disability, affecting more than 3 billion people around the world, a comprehensive new analysis showed.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Neurological Disorders Now Top Cause of Illness, Disability Neurological Disorders Now Top Cause of Illness, Disability
Neurological conditions are now the leading cause of illness and disability, affecting more than 3 billion people around the world, a comprehensive new analysis showed.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Clemastine Tied to Worsening Symptoms in Multidrug MS Trial Clemastine Tied to Worsening Symptoms in Multidrug MS Trial
Worsening symptoms among several patients with MS taking the OTC antihistamine clemastine prompted investigators to halt that arm of a multidrug trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

An Easy, Effective Solution to Heat Sensitivity in RRMS? An Easy, Effective Solution to Heat Sensitivity in RRMS?
Aspirin and acetaminophen may offer an effective and inexpensive solution to exercise-induced heat sensitivity in relapsing-remitting multiple sclerosis, phase 3 data suggested.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Obstructive Sleep Apnea Linked to Higher Stroke Risk Obstructive Sleep Apnea Linked to Higher Stroke Risk
Obstructive sleep apnea is linked to a higher risk of incident stroke regardless of CPAP use – but only in White individuals.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 13, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Watchdog Group: Remove ALS Drug Relyvrio From Market Now Watchdog Group: Remove ALS Drug Relyvrio From Market Now
The watchdog group Public Citizen is calling for the prompt removal of the ALS drug Relyvrio after it failed to meet primary and secondary endpoints in top-line results from a phase 3 trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 13, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Infant Exposure to MS Drugs via Breastfeeding: New Data Infant Exposure to MS Drugs via Breastfeeding: New Data
Infant exposure to monoclonal antibodies used to treat MS via breast milk does not negatively affect health or development out to 3 years, a new study shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 12, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news